Evidence map›Paper›PMID 38197661›Full record

ArticleMicrobiology spectrum2024

Nosocomial surveillance of multidrug-resistant

Zhimei Duan, Xuming Li, Song Li, Hui Zhou, Long Hu, Han Xia, Lixin Xie, Fei Xie

Abstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Drug-resistantClinical microbiology reviews · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. High-Resolution Genomic Surveillance of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Genomic Epidemiology of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  11. Article
  12. Article
  13. Genomic characterization of carbapenem-resistantFrontiers in cellular and infection microbiology · 2026
    Article
  14. Article
  15. Colonization of the gut byFrontiers in cellular and infection microbiology · 2026
    Article
  16. Article
  17. Article
  18. Incidence of drug resistance and expression ofIranian journal of microbiology · 2025
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhimei Duan *College of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital, Beijing, China.ORCID 0000-0002-6076-5406
Xuming Li *Department of Scientific Affairs, Hugobiotech Co., Ltd., Beijing, China.ORCID 0000-0002-5049-9706
Song LiDepartment of Scientific Affairs, Hugobiotech Co., Ltd., Beijing, China.ORCID 0000-0002-8992-487X
Hui ZhouDepartment of Scientific Affairs, Hugobiotech Co., Ltd., Beijing, China.
Long HuDepartment of Scientific Affairs, Hugobiotech Co., Ltd., Beijing, China.ORCID 0000-0003-2120-3416
Han XiaDepartment of Scientific Affairs, Hugobiotech Co., Ltd., Beijing, China.ORCID 0000-0002-5179-0255
Lixin XieCollege of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital, Beijing, China.ORCID 0000-0002-1091-2041
Fei XieCollege of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital, Beijing, China.ORCID 0000-0003-3674-8216

Funding

CFH |Capital's Funds for Health Improvement and Research 2022-1-5091Chinese PLA General Hospital Fund CX19030, 2017MBD-011, 2018FC-WJFWZX-2-04Fund BLB20J002MOST | National Key Research and Development Program of China (NKPs) 2019YFC0121703MOST | National Natural Science Foundation of China (NSFC) 61976223
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acinetobacter baumanniiCross InfectionAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialGenomicsHospitalsHumansInterleukin-1 Receptor-Like 1 ProteinMicrobial Sensitivity TestsPhylogenyAnti-Bacterial AgentsInterleukin-1 Receptor-Like 1 ProteinAcinetobacter baumanniiantimicrobial resistance testingepidemiologygenome typingpopulation genomicswhole genome sequencing

Identifiers

PMID38197661
PMCPMC10846281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.